Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Cattle vaccination will not work on its own
AHVLA scientists comment on TB vaccine

Cattle vaccination against bovine tuberculosis could offer farmers an important tool to help prevent TB infection in their herds, but it will not wipe out the disease completely.

Glyn Hewinson, chief scientist at the Animal Health and Veterinary Laboratories Agency (AHVLA), commented that he did not think that cattle vaccination "can be a strategy on its own - you have to use all the tools in your toolbox," but he added that "the level of investment that's going into the development of TB vaccines shows the commitment to develop these important tools to control TB in the UK."

Defra has budgeted £15.5 million for research into developing effective cattle TB vaccines over the next four years, and the AHVLA has developed a blood test - a DIVA test - which can distinguish between infected and vaccinated animals.

Defra is currently working with the EU to change legislation to allow a BCG cattle vaccine and the DIVA to be used in combination to tackle bovine TB, with the aim of allowing both to be used legally in the UK.

However, Defra secretary Owen Paterson has insisted that vaccination is still not a viable alternative to badger culling. Speaking at a meeting of the Conservative Rural Affairs Group, in Birmingham, he said that currently, vaccines are "not yet in a position to be deployed" in either cattle or badgers.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.